NASD · Healthcare · Pharmaceutical Retailers · USA
Scienture Holdings Inc is a micro cap company (market value under $300 million) in the Pharmaceutical Retailers industry.
Scienture Holdings is a specialty pharmaceutical company that commercializes and develops medicines for cardiovascular and central nervous system diseases. It markets products addressing hypertension and opioid overdose treatment, with a pipeline of candidates targeting migraine, thrombosis, pain and related conditions.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Scienture Holdings Inc stock.
Not valued: We cannot value this company yet.
We do not publish a value for this company: not even its current assets cover what it owes.
We do not publish a verdict on SCNX yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.
We do not publish one (as of the 2026-10-30 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.